The Vox Markets Podcast / Neil Clark of Destiny Pharma discusses new research programme and progress on lead clinical assets

View our embed guidelines

Sorry, your browser isn't supported.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.